Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response?

Area of Science:

• Radiotherapy
• Medical Imaging
• Oncology

Background:

• Hypoxia is a known factor in radioresistance.
• Predictive biomarkers are needed to optimize stereotactic ablative radiotherapy (SABR).
• Oxygen-sensitive magnetic resonance imaging (MRI) is a potential tool to assess tumor hypoxia.

Purpose of the Study:

• To develop a noninvasive prognostic imaging biomarker for hypoxia.
• To predict tumor control following SABR.
• To evaluate oxygen-sensitive MRI as a predictive tool.

Main Methods:

• 145 Dunning prostate rat tumors were irradiated with doses ranging from 0 to 100 Gy.
• Oxygen-sensitive MRI (T1-weighted, ΔR1, ΔR2*) was used to assess tumor hypoxia.
• Tumor control was evaluated up to 200 days post-irradiation.

Main Results:

• Increasing radiation dose improved tumor control.
• Oxygen breathing during irradiation showed a modest benefit.
• Oxygen-sensitive MRI signal response (%ΔSI) stratified tumors for local control at 40 Gy.
• Tumors with %ΔSI >0.922 showed significantly better control (75% vs 0%).
• A 50 Gy dose overcame hypoxia-related resistance in 50% of tumors.

Conclusions:

• Oxygen-sensitive MRI can stratify tumors based on local control.
• This technique shows potential as a predictive imaging biomarker for SABR.
• Higher radiation doses can overcome hypoxia-induced radioresistance.